nach oben

International Urology and Nephrology

Erschienen in:

23.02.2018 | Nephrology - Original Paper

Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies

verfasst von: Haili Xu, Jinliu Suo, Jing Lian

Erschienen in: International Urology and Nephrology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to assess the effects of smoking on albuminuria risk in adults with type 2 diabetes mellitus (T2DM).

Methods

A literature search was conducted using MEDLINE, EMBASE, and China National Knowledge Infrastructure from the established date to October 2017. Summary relative risks (SRR) and 95% confidence intervals (CI) were computed utilizing a random effect inverse variance method.

Results

This meta-analysis included a total of 19 relevant observational studies (four prospective cohort, seven case–control, and eight cross-sectional studies), reporting 105,031 participants and 23,366 albuminuria events. Compared with never-smokers with T2DM, the SRRs of albuminuria were 1.43 (95% CIs 1.27–1.61) for ever-smokers, 2.61 (95% CIs 1.86–3.64) for current smokers, and 1.86 (95% CIs 1.37–2.52) for former smokers. Considerable heterogeneity was observed among these studies, and study design was a significant modifier for this association. There were significantly elevated risk associations for microalbuminuria (SRRs = 1.24, 95% CIs 1.05–1.46) and for macroalbuminuria (SRRs = 1.65, 95% CIs 1.03–2.66), respectively.

Conclusions

Our systematic review and meta-analysis indicates that cigarette smoking might be a potential factor for the development of albuminuria in adults with T2DM. Future studies are required to investigate the association between smoking cessation and intensity and incident albuminuria in adults with T2DM.

Nur mit Berechtigung zugänglich

Keen H, Chlouverakis C, Fuller J et al (1969) The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guys Hosp Rep 118(2):247–254PubMed

Viberti GC, Hill RD, Jarrett RJ et al (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1(8287):1430–1432CrossRefPubMed

Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310(6):356–360CrossRefPubMed

Bakris GL, Molitch M (2014) Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care 37(3):867–875CrossRefPubMed

Tebbe U, Bramlage P, Thoenes M et al (2009) Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. Swiss Med Wkly 139(33–34):473–480PubMed

Ahn JH, Yu JH, Ko SH et al (2014) Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey. Diabetes Metab J 38(2):109–119CrossRefPubMedPubMedCentral

Thompson JL, Allen P, Cunningham-Sabo L et al (2002) Environmental, policy, and cultural factors related to physical activity in sedentary American Indian women. Women Health 36(2):59–74CrossRefPubMed

Radcliffe NJ, Seah JM, Clarke M et al (2017) Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig 8(1):6–18CrossRefPubMed

Xue R, Gui D, Zheng L et al (2017) Mechanistic insight and management of diabetic nephropathy: recent progress and future perspective. J Diabetes Res 2017:1839809CrossRefPubMedPubMedCentral

10.

Linneberg A, Jacobsen RK, Skaaby T et al (2015) Effect of smoking on blood pressure and resting heart rate: a mendelian randomization meta-analysis in the CARTA consortium. Circ Cardiovasc Genet 8(6):832–841CrossRefPubMedPubMedCentral

11.

Li WH, Wang MP, Lam TH et al (2017) Brief intervention to promote smoking cessation and improve glycemic control in smokers with type 2 diabetes: a randomized controlled trial. Sci Rep 7:45902CrossRefPubMedPubMedCentral

12.

Yeom H, Lee JH, Kim HC et al (2016) The association between smoking tobacco after a diagnosis of diabetes and the prevalence of diabetic nephropathy in the Korean male population. J Prev Med Public Health 49(2):108–117CrossRefPubMedPubMedCentral

13.

Zhang W, Yang Z, Li X et al (2015) The functional Q84R polymorphism of TRIB3 gene is associated with diabetic nephropathy in Chinese type 2 diabetic patients. Gene 555(2):357–361CrossRefPubMed

14.

Furukawa S, Yamamoto S, Todo Y et al (2014) Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus. Endocr J 61(10):1011–1018CrossRefPubMed

15.

Wolf G, Busch M, Muller N et al (2011) Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre. Nephrol Dial Transplant 26(12):4017–4023CrossRefPubMed

16.

Hsu CC, Hwang SJ, Tai TY et al (2010) Cigarette smoking and proteinuria in Taiwanese men with Type 2 diabetes mellitus. Diabet Med 27(3):295–302CrossRefPubMed

17.

Parving HH, Lewis JB, Ravid M et al (2006) Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 69(11):2057–2063CrossRefPubMed

18.

Hou XH, Wang JH, Feng P et al (2005) A case control study on the risk factors of proteinuria in patients with type 2 diabetes. Zhonghua Liu Xing Bing Xue Za Zhi 26(1):39–43PubMed

19.

Herrera-Pombo JL, Aguilar-Diosdado M, Hawkins F et al (2005) Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? Nephron Clin Pract 101(3):c116–c121CrossRefPubMed

20.

Cederholm J, Eliasson B, Nilsson PM et al (2005) Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 67(3):258–266CrossRefPubMed

21.

Tam TK, Cheng LP, Lau DM et al (2004) The prevalence of microalbuminuria among patients with type II diabetes mellitus in a primary care setting: cross-sectional study. Hong Kong Med J 10(5):307–311PubMed

22.

Kohler KA, McClellan WM, Ziemer DC et al (2002) Smoking and microalbuminuria: a case-control study in African-Americans with type 2 diabetes. Diabetes Care 25(1):243–245CrossRefPubMed

23.

Pijls LT, de Vries H, Kriegsman DM et al (2001) Determinants of albuminuria in people with Type 2 diabetes mellitus. Diabetes Res Clin Pract 52(2):133–143CrossRefPubMed

24.

Yokoyama H, Okudaira M, Otani T et al (1998) High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis. Diabetes Care. 21(7):1080–1085CrossRefPubMed

25.

Klein R, Klein BE, Moss SE et al (1995) Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 44(8):916–923CrossRefPubMed

26.

Al-Rubeaan K, Youssef AM, Subhani SN et al (2014) Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PLoS ONE 9(2):e88956. https://doi.org/10.1371/journal.pone.0088956 CrossRefPubMedPubMedCentral

27.

Liu L, Zheng T, Wang F et al (2010) Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Care 33(1):144–149. https://doi.org/10.2337/dc09-1258 CrossRefPubMed

28.

Aekplakorn W, Srivanichakorn S, Sangwatanaroj S (2009) Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand. Diabetes Res Clin Pract 84(1):92–98. https://doi.org/10.1016/j.diabres.2008.12.020 CrossRefPubMed

29.

Unnikrishnan RI, Rema M, Pradeepa R et al (2007) Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 30(8):2019–2024. https://doi.org/10.2337/dc06-2554 CrossRefPubMed

30.

Amini M, Safaei H, Aminorroaya A (2007) The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in Isfahan, Iran. Rev Diabet Stud 4(4):242–248. https://doi.org/10.1900/RDS.2007.4.242 CrossRefPubMed

31.

Su S, Wang W, Sun T et al (2017) Smoking as a risk factor for diabetic nephropathy: a meta-analysis. Int Urol Nephrol 49(10):1801–1807. https://doi.org/10.1007/s11255-017-1638-3 CrossRefPubMed

32.

Jiang N, Huang F, Zhang X (2017) Smoking and the risk of diabetic nephropathy in patients with type 1 and type 2 diabetes: a meta-analysis of observational studies. Oncotarget 8(54):93209–93218. https://doi.org/10.18632/oncotarget.21478 PubMedPubMedCentral

33.

Kramer HJ, Nguyen QD, Curhan G et al (2003) Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289(24):3273–3277. https://doi.org/10.1001/jama.289.24.3273 CrossRefPubMed

34.

Yokoyama H, Sone H, Oishi M et al (2009) Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 24(4):1212–1219. https://doi.org/10.1093/ndt/gfn603 CrossRefPubMed

35.

Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMed

36.

Ovbiagele B (2008) Microalbuminuria: risk factor and potential therapeutic target for stroke? J Neurol Sci 271(1–2):21–28CrossRefPubMed

37.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed

38.

Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557 CrossRefPubMedPubMedCentral

39.

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRefPubMed

40.

Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefPubMedPubMedCentral

41.

Chen Y, Zhi Y, Li C et al (2016) HDL cholesterol and risk of diabetic nephropathy in patient with type 1 diabetes: a meta-analysis of cohort studies. Diabetes Res Clin Pract 122:84–91CrossRefPubMed

42.

Barua RS, Ambrose JA (2013) Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol 33(7):1460–1467CrossRefPubMed

43.

Caimi G, Hopps E, Montana M et al (2014) Nitric oxide metabolites (nitrite and nitrate) in several clinical condition. Clin Hemorheol Microcirc. 56(4):359–369PubMed

44.

Salvatore SP, Troxell ML, Hecox D et al (2015) Smoking-related glomerulopathy: expanding the morphologic spectrum. Am J Nephrol 41(1):66–72CrossRefPubMed

45.

Baggio B, Budakovic A, Dalla Vestra M et al (2002) Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol 13(11):2730–2736CrossRefPubMed

46.

Jose MJ, Varkey V, Chandni R et al (2016) The Role of Smoking as a Modifiable Risk Factor in Diabetic Nephropathy. J Assoc Physicians India 64(7):34–38PubMed

47.

Lan L, Han Y, Ren W et al (2015) Advanced glycation endproducts affect the cytoskeletal structure of rat glomerular endothelial cells via the Rasrelated C3 botulinum toxin substrate 1 signaling pathway. Mol Med Rep. 11(6):4321–4326CrossRefPubMed

48.

Pala L, Cresci B, Manuelli C et al (2005) Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: biological effects and advanced glycosilation end products modulation. Microvasc Res 70(3):179–188CrossRefPubMed

49.

Chuahirun T, Simoni J, Hudson C et al (2004) Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 327(2):57–67CrossRefPubMed

50.

Phisitkul K, Hegazy K, Chuahirun T et al (2008) Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci 335(4):284–291. https://doi.org/10.1097/MAJ.0b013e318156b799 CrossRefPubMed

51.

Launay JM, Del Pino M, Chironi G et al (2009) Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS ONE 4(11):e7959CrossRefPubMedPubMedCentral

52.

Hellemons ME, Agarwal PK, van der Bij W et al (2011) Former smoking is a risk factor for chronic kidney disease after lung transplantation. Am J Transplant 11(11):2490–2498CrossRefPubMed

53.

Bowlin SJ, Morrill BD, Nafziger AN et al (1996) Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: the behavioral risk factor survey. J Clin Epidemiol 49(5):511–517CrossRefPubMed

54.

Orth SR, Stockmann A, Conradt C et al (1998) Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54(3):926–931. https://doi.org/10.1046/j.1523-1755.1998.00067.x CrossRefPubMed

Titel: Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies
verfasst von: Haili Xu
Jinliu Suo
Jing Lian
Publikationsdatum: 23.02.2018
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 5/2018
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-018-1825-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients

Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters

Knocking down Cabin1 induces glomerular podocyte injury

The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review